Abstracts

1332 – Point-of-Care Urine Self-Testing Feasibility to Measure TFV Adherence and Predict Viral Suppression

Background Only 68% of U.S. men-who-have-sex-with-men (MSM) living with HIV have achieved virologic suppression (VS), sufficiently low to compromise Ending the HIV Epidemic goals. Objective monitoring of antiretroviral therapy (ART) adherence via drug-level testing can inform interventions. A rapid, low-cost urine point-of-care (POC) tenofovir (TFV) assay has been developed by our group as an objective…

1318 – Home CAB/RPV Provides Novel Approach to Achieve Viral Suppression in PWH With Adherence Challenges

Background Cabotegravir/Rilpivirine (CAB/RPV) demonstrated superiority to oral ART in persons living with HIV (PWH) with adherence challenges. We evaluate an innovative support services program, including home administration of injections, to support CAB/RPV adherence in PWH. Methods In 2016, Whitman-Walker Health initiated the Mobile Outreach Retention and Engagement Program (MORE) to support adult PWH with adherence…

1361 – Longitudinal Renal Safety of a Population-Level TDF-Based HIV PrEP Program in British Columbia

Background Since 1-Jan-2018, publicly-funded oral HIV Pre-Exposure Prophylaxis (PrEP) with generic emtricitabine-tenofovir disoproxil fumarate (FTC-TDF) has been available to key HIV populations in British Columbia (BC). We examined the renal safety of over 10,000 clients on FTC-TDF in BC’s population-level PrEP program. Methods Using data from BC’s PrEP program, we included clients with ≥1 FTC-TDF PrEP…

1347 – PrEP Use Trajectories and HIV Incidence Among PrEP Users in Brazil: Findings From the ImPrEP Study

Background New HIV cases continue to rise in Latin America, especially among young men who have sex with men (MSM) and transgender women (TGW). Understanding long-term oral PrEP use is crucial for improving adherence and retention to services. This study explored PrEP use patterns over time in Brazil, identifying distinct trajectories and associated factors. Methods…

1325 – Impact of Differentiated HIV Service Delivery Models on Quality of Life in Uganda

Background Differentiated service delivery (DSD) models have reduced strain on health services and improved client experience, retention and viral suppression, but little is known about the impact of HIV DSD models on quality of life (QoL), which is essential for optimizing person-centered care. This study assessed the impact of DSD models on QoL, loss to follow-up (LTFU), and mortality among persons living with…

1297 – Impact of Rapid Long-Acting PrEP Scale-Up Among MSM: Closing the Unmet Needs and Towards Ending HIV

Background Long-acting injectable cabotegravir (CAB-LA) is superior to oral pre-exposure prophylaxis (PrEP) regimens. The slow scale-up of oral PrEP has left significant gaps in HIV prevention among men who have sex with men (MSM), and global HIV prevention targets have been missed. The introduction of CAB-LA could facilitate broader prevention choices and help reach these targets.…

1301 – Impact of SEARCH Person-Centered Care/Prevention on Clinical Outcomes by Alcohol Use in East Africa

Background Person-centered HIV care and prevention that provide low-barrier access and non-judgmental interactions may address poor outcomes among persons with alcohol use. Alcohol use is a risk factor for: a) non-retention in care and viremia among PWH, and b) non-retention in biomedical prevention and HIV acquisition among persons without HIV. We sought to determine if…

1314 – Hair Salons as a Promising Space to Offer HIV Prevention Services for Young Women in Lesotho

Background Adolescent girls and young women in southern Africa are disproportionately affected by HIV and sexual reproductive health (SRH) challenges. There is a need for more accessible and de-medicalized community spaces to offer person-centred HIV/SRH services for this key population. We aimed to assess the acceptability and feasibility of offering HIV/SRH services at hair salons…